Public-ready7/2/2026

NAC

Papers analyzed

109

Blood-Level or Deficiency MarkerFatigue and energyGlucose and metabolic health markers

What to look for in this research

Blood-Level or Deficiency Marker is closer to a research marker, so it should be read separately from a directly felt benefit.

Main benefit evidence

Review human evidence by goal.

Nutrient status and deficiency

Blood-Level or Deficiency Marker

Measured outcomes: Blood level or deficiency correction markers

This is based on lab markers such as blood levels, deficiency correction, or absorption. Read it separately from directly felt outcomes.

Goal tierNot rated yet

The currently linked research coverage is not broad enough to characterize this goal yet.

Check this goal in more detail

Fatigue and energy

Measured outcomes: Fatigue and energy

Potential benefit studied in Fatigue and energy.

Goal tierNot rated yet

The currently linked research coverage is not broad enough to characterize this goal yet.

Check this goal in more detail

Glucose and metabolic health

Glucose and metabolic health markers

Measured outcomes: Glucose and metabolic markers

This card is closer to a measured biomarker or lab outcome than a directly felt user benefit. These findings come from a defined study population, so everyday effects may differ.

Goal tierNot rated yet

The currently linked research coverage is not broad enough to characterize this goal yet.

Check this goal in more detail

Stress and mood

Stress Response and Sleep Changes

Measured outcomes: Stress and mood balance

These findings come from stress response, cortisol, anxiety, or sleep outcomes. They may mix felt benefits with physiological markers.

Goal tierNot rated yet

The currently linked research coverage is not broad enough to characterize this goal yet.

Check this goal in more detail

What does a research result actually tell you?

Reading research

Improvement after a supplement is not the same as a comparative result

Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.

No significant difference and an unreadable result mean different things

A reported null comparison contains a result. An abstract without an interpretable comparison leaves a question unresolved.

Ten papers do not necessarily mean ten independent studies

Count original research separately from research that reanalyzes it. Publication volume is neither replication nor a quality rating.

Side effects and combination findings in studies

Findings from studies of this ingredient alone are separated from findings involving another supplement or medication.

Caution signals

Side effects + combos + curated rules

Key precautions

No curated contraindication rule is available yet, but literature caution signals are shown below.

1 combo signals and 0 added-signal combos shown below.

These are signals reported in studies. They do not predict what will happen to an individual.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported when this ingredient was used alone

Symptoms or adverse events reported in studies of this ingredient without another active ingredient.

Adverse Events from NAC1 papers

The most frequent adverse events reported with NAC were anaphylactic reactions, cutaneous reactions for IV route, and intestinal reactions for oral route.Human studies · Systematic review

Adverse effect signal1 papers

The most frequent adverse events reported with NAC use were anaphylactic reactions, followed by cutaneous adverse events for the intravenous route and intestinal adverse events for the oral route.Human studies · Study type not identified

Potential side effects1 papers

The review discusses potential side effects of NAC and its formulations for drug delivery without specifying severity or frequency.Human studies · Systematic review

Minor adverse events1 papers

The meta-analysis reports that N-acetylcysteine is associated with minor adverse events, though the overall tolerability is described as good.Human studies · Meta-analysis

Gastrointestinal symptoms1 papers

Gastrointestinal symptoms were significantly greater in the NAC group compared to the placebo group in a 16-week RCT.Human studies · Randomized controlled trial

Gastrointestinal adverse events1 papers

Nine drug-related gastrointestinal adverse events occurred, which resolved spontaneously or with dose reduction, indicating a mild safety signal.Human studies · Randomized controlled trial

Adverse events and tolerability1 papers

Three participants discontinued the trial due to adverse effects, though the overall frequency of adverse events was low and not statistically different between groups.Human studies · Randomized controlled trial

Adverse events (abdominal discomfort, muscle pains, insomnia, headache, etc.)1 papers

NAC was generally well tolerated with 63% of participants reporting mild to moderate adverse events such as abdominal discomfort, muscle pains, and insomnia, none leading to discontinuation.Human studies · Randomized controlled trial

Positive combinations studied

Positive combination findings are separated by how the study compared the groups. This is not a recommendation to combine them.

Positive findings when used together

The combination had a positive result, but the contribution of each ingredient could not be separated.

GlycineIn a randomized clinical trial of older adults, GlyNAC (a combination of glycine and NAC) supplementation for 16 weeks improved glutathione deficiency, oxidative stress, and mitochondrial dysfunction compared to placebo.

NAC

arrow_backBack to list